Arkolith/Insider Trading/AMRX/Form 4

Autor Deborah M.

DirectorAmneal Pharmaceuticals, Inc. (AMRX) · full profile →Form 4 · filed May 12, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$451K
Net Open-Market Flow
-$451K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 11, 2026Sell(S)35K$12.94$451K94K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-26-034106) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML